Filing Details
- Accession Number:
- 0001179110-14-003304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-21 14:32:06
- Reporting Period:
- 2014-02-19
- Filing Date:
- 2014-02-21
- Accepted Time:
- 2014-02-21 14:32:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1216923 | G Nicholas Moore | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-19 | 19,068 | $22.02 | 19,068 | No | 4 | M | Indirect | by Trust |
Common Stock | Disposition | 2014-02-19 | 7,176 | $83.51 | 11,892 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2014-02-19 | 11,892 | $82.89 | 0 | No | 4 | S | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2014-02-19 | 19,068 | $0.00 | 19,068 | $22.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-05-06 | No | 4 | M | Indirect |
Footnotes
- Options vest quarterly over a period of one year from the date of grant.
- Sale prices reported for the transactions reported here range from $83.35 to $83.79. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $82.35 to $83.34. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.